News Ticker

[ October 9, 2026 ] Four new life sciences departments showcase USC Dornsife’s strengths in biology Los Angeles Biotech News
[ October 9, 2026 ] Diabetes Sales Associate Los Angeles Biotech Jobs
[ October 9, 2026 ] Strongpoint Partners Platform Grows with Addition of Hilde Minkel & Associates Los Angeles Biotech News
[ October 9, 2026 ] HICE and Gabeo.ai Join Forces to Advance Transparency in Healthcare Risk Contracts Los Angeles Biotech News
[ October 8, 2026 ] SELENA GOMEZ ANNOUNCES LEON BRIDGES AND BELLA KAY AS ENTERTAINMENT FOR THE FOURTH ANNUAL RARE IMPACT FUND BENEFIT Los Angeles Biotech News

jCyte Inc. Enters into Ex-US Licensing and Commercialization Agreement for jCell Therapy with Global Ophthalmology Leader Santen Pharmaceutical

May 8, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte Inc. Enters into Ex-US Licensing and Commercialization Agreement for jCell Therapy with Global Ophthalmology Leader Santen Pharmaceutical

Copyright © 2026 Biotech Networks, LLC